A Randomized, Parallel Group, Double-Blind Study of Ticagrelor Compared With Aspirin for Prevention of Vascular Events in Patients Undergoing Coronary Artery Bypass Graft Operation TiCAB- Ticagrelor in CABG

Trial Profile

A Randomized, Parallel Group, Double-Blind Study of Ticagrelor Compared With Aspirin for Prevention of Vascular Events in Patients Undergoing Coronary Artery Bypass Graft Operation TiCAB- Ticagrelor in CABG

Recruiting
Phase of Trial: Phase III

Latest Information Update: 08 May 2017

At a glance

  • Drugs Ticagrelor (Primary) ; Aspirin
  • Indications Acute coronary syndromes; Coronary artery disease; Stroke; Thrombosis; Venous thromboembolism
  • Focus Adverse reactions
  • Acronyms TiCAB
  • Most Recent Events

    • 05 May 2017 This trial has been suspended in Germany as per European Clinical Trials Database record.
    • 30 Mar 2017 This trial has been suspended in Austria.
    • 01 Sep 2016 Trial design published in the American Heart Journal.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top